Evaluation of the effect of continuous infusion recombinant interleukin-2 (bioleukin) on peripheral blood leucocytes of patients with terminal malignancy.

Seventeen patients with terminal malignancy have been entered into a sequential investigation of two doses of continuous infusion recombinant interleukin-2 (bioleukin) given in the setting of a general ward. After an initial experience of a dose of 300 micrograms m-2 in eight patients the remainder...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliver, R. T., Crosby, D., Nouri, A., Scott, E., Galazka, A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1989
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247261/
https://www.ncbi.nlm.nih.gov/pubmed/2605101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247261/
https://www.ncbi.nlm.nih.gov/pubmed/2605101

Ejemplares similares